Skip to main content
SpringerLink
Log in

Ansprechen schizophrener Patienten auf Risperidon

Die Rolle des Kaliumkanal-Genotyps und des Risperidon-Metabolisiererstatus

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Referenzen

  1. Apud JA et al. Am J Psychiatry 2012; 169: 725–34

    Article  PubMed  Google Scholar 

  2. Lieberman JA et al. N Engl J Med 2005; 353: 1209–23

    Article  CAS  PubMed  Google Scholar 

  3. Mannheimer B et al. Ther Drug Monit 2016; 38: 127–34

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Heide J, Zhang F, Bigos KL et al. Differential response to risperidone in schizophrenia patients by KCNH2 genotype and drug metabolizer status. Am J Psychiatry 2016; 173: 53–9

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Mainz, Mainz, Deutschland

    Christoph Hiemke

Authors
  1. Christoph Hiemke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Hiemke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hiemke, C. Die Rolle des Kaliumkanal-Genotyps und des Risperidon-Metabolisiererstatus. InFo Neurologie 18, 20–21 (2016). https://doi.org/10.1007/s15005-016-1874-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-016-1874-6

Search

Navigation